XML 30 R8.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Divestiture | 3 Months Ended
--- | ---
Mar. 31, 2017
Divestiture and Acquisition [Abstract] |
DIVESTITURE | DIVESTITURE Spin-off of Nuvectra Corporation On March 14, 2016, Integer completed the spin-off of a portion of its former QiG segment through a tax-free distribution of all of the shares of its QiG Group, LLC subsidiary to the stockholders of Integer on a pro rata basis. Immediately prior to completion of the Spin-off, QiG Group, LLC was converted into a corporation organized under the laws of Delaware and changed its name to Nuvectra Corporation (“Nuvectra”). On March 14, 2016, each of the Company’s stockholders of record as of the close of business on March 7, 2016 received one share of Nuvectra common stock for every three shares of Integer common stock held as of that date. Upon completion of the Spin-off, Nuvectra became an independent publicly traded company whose common stock is listed on the NASDAQ stock exchange under the symbol “NVTR.” The portion of the QiG segment spun-off consisted of QiG Group, LLC and its subsidiaries: (i) Algostim, LLC (“Algostim”), (ii) PelviStim LLC (“PelviStim”), and (iii) the Company’s NeuroNexus Technologies (“NeuroNexus”) subsidiary. The operations of Centro de Construcción de Cardioestimuladores del Uruguay (“CCC”) and certain other existing QiG research and development capabilities were retained by the Company and not included as part of the Spin-off. As the Company continues to focus on the design and development of complete medical device systems and components, and more specifically on medical device systems and components in the neuromodulation market, the Spin-off was not considered a strategic shift that had a major effect on the Company’s operations and financial results. Accordingly, the Spin-off is not presented as a discontinued operation in the Company’s Condensed Consolidated Financial Statements. The results of Nuvectra are included in the Condensed Consolidated Statements of Operations and Comprehensive Income through the date of the Spin-off. In connection with the Spin-off, during the first quarter of 2016, the Company made a cash capital contribution of $75 million to Nuvectra and divested the following assets and liabilities (in thousands):
Assets divested |
Cash and cash equivalents | $ | 76,256 |
Other current assets | 977 |
Property, plant and equipment, net | 4,407 |
Amortizing intangible assets, net | 1,931 |
Goodwill | 40,830 |
Deferred income taxes | 6,446 |
Total assets divested | 130,847 |
Liabilities transferred |
Current liabilities | 2,119 |
Net assets divested | $ | 128,728 |
For the first quarter of 2016, Nuvectra contributed a pre-tax loss of $5.2 million to the Company’s results of operations. In connection with the Spin-off, on March 14, 2016, Integer entered into several agreements with Nuvectra that govern its post Spin-off relationship with Nuvectra, including a Separation and Distribution Agreement, Tax Matters Agreement, Employee Matters Agreement and Transition Services Agreement. The Transition Services Agreement contains customary mutual indemnification provisions. Amounts earned by Integer under the Transition Services Agreement were immaterial for the three month periods ended March 31, 2017 and April 1, 2016.

X
- Definition Divestiture And Business Combination Disclosure [Text Block] + References No definition available. + Details
Name: | gb_DivestitureAndBusinessCombinationDisclosureTextBlock
Namespace Prefix: | gb_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Divestiture and Acquisition [Abstract] + References No definition available. + Details
Name: | gb_DivestitureandAcquisitionAbstract
Namespace Prefix: | gb_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration